A team led by the Institute for Bioengineering of Catalonia (IBEC) and the Hospital del Mar Research Institute has developed ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

A group of scientists in China has revealed a novel mechanism whereby a short form of IL-18, generated by caspase-3 cleavage ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful, ...

Mayo Clinic, Mount Sinai and Huntsman Cancer Insitute are delivering services from chemotherapy to imaging in cancer patients ...

Paul Nghiem, MD, PhD, and the Nghiem Lab have championed innovations in MCC treatment, delivering new treatment options, ...

The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference ...

Mangaluru: A heart-warming display of generosity unfolded as a social media appeal helped raise Rs 95 lakh for four-year-old Mohammad Muhad, who is ba.

Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025SOUTH SAN FRANSCISCO, Calif., ...

BMS acquired Cobenfy as part of its $14 billion takeover of Karuna Therapeutics towards the end of 2023, and analysts at ...